Political Climate and Job Market Concerns Drive Biopharma Professionals to Consider Work Abroad

A recent survey by BioSpace reveals a significant trend in the biopharmaceutical industry: a substantial number of professionals are contemplating leaving the United States to pursue career opportunities abroad. This shift is primarily driven by concerns over the current political climate and challenges in the domestic job market.

Survey Findings and Industry Trends

According to the BioSpace survey conducted in May, 30% of employed and 48% of unemployed respondents are seriously considering relocating internationally for biotech or pharma work. The trend is particularly pronounced among those who have been unemployed for three months or less, with 58% of this group expressing interest in overseas opportunities.

The survey results come amid a backdrop of industry-wide challenges. In the first quarter of 2025, biopharma companies laid off 6,044 employees, marking a 24% increase compared to the same period in 2024. However, there was a slight improvement in April, with layoffs decreasing by 22% year-over-year to 1,368.

Political Climate's Impact on Biopharma

The current political environment in the United States is a significant factor influencing professionals' decisions to consider work abroad. Bryan Blair, vice president of life sciences at talent solutions firm GQR, noted that job candidates are increasingly inquiring about international opportunities, with female candidates more likely to cite political concerns as a motivating factor.

Survey respondents expressed frustration with the Trump administration's impact on the industry. One participant commented, "The long-term environment will be damaged for years, if not decades, after this administration. There will be more, and better, opportunities outside of the US."

Job Market Saturation and Limited Opportunities

The domestic job market's challenges are another key driver for professionals considering international moves. Multiple survey respondents reported difficulties in finding suitable positions, with one stating, "It's been 9+ months of trying to find another opportunity that matches my experience and offers either remote flexibility or relocation assistance."

BioSpace data for April indicates an 8% year-over-year decrease in overall biopharma hiring activity. Industry experts predict that a significant turnaround in the job market is unlikely to occur until 2026, citing the need for increased investment and the impact of industry uncertainty.

Some professionals are exploring opportunities in emerging markets such as China, where there is a growing demand for talent due to recent biotech sector growth. However, Tim Scott, president and CEO of Biocom California, noted that opportunities in Europe might be more limited compared to the United States.

As the industry grapples with these challenges, talent retention could become increasingly critical for companies. The potential brain drain, while not currently a top concern for many businesses, is on their radar. The situation poses a particular threat to biotech startups, which rely heavily on access to talent, funding, and workspace to thrive in the competitive landscape.